Gen-Probe Reports 5 Percent Q3 Revenue Growth, Takes Loss on PacBio Investment | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe's revenues rose 5 percent year over year for the third quarter but fell short of analyst expectations, the San Diego molecular diagnostics company reported after the close of the market on Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.